Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gulf Medical Projects Co PSCADX:GMPC -3.35%69 EBITDA Margin % is 23.09% as of Dec. 2025, which is 8% above its 10-year median of 21.46. GuruFocus rates ADX:GMPC with a GF Score™ of 69/100 and a GF Value™ of د.إ2.78 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Gulf Medical Projects Co PSC ranks better than 81.33% on this metric.
Gulf Medical Projects Co PSC (ADX:GMPC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Gulf Medical Projects Co PSC EBITDA Margin % Related Terms
Gulf Medical Projects Co PSC EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Medical Projects Co PSC EBITDA Margin % Chart
ADX:GMPC vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Gulf Medical Projects Co PSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gulf Medical Projects Co PSC EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gulf Medical Projects Co PSC's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Gulf Medical Projects Co PSC's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Medical Projects Co PSC (ADX:GMPC) has a EBITDA Margin % of 23.09% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gulf Medical Projects Co PSC and its competitors. This is near median its historical median of 21.46. Over the past decade, Gulf Medical Projects Co PSC's EBITDA Margin % has ranged from 18.06 to 28.44. According to the industry distribution chart, Gulf Medical Projects Co PSC ranks #124 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 18.7%.
Is Gulf Medical Projects Co PSC's EBITDA Margin % too high?
Gulf Medical Projects Co PSC's current EBITDA Margin % of 23.09% is near median its 10-year median of 21.46. Over the past 10 years, this metric has ranged from a low of 18.06 to a high of 28.44. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Gulf Medical Projects Co PSC's value of 23.09% is 125.6% above this industry median. Based on the distribution chart, Gulf Medical Projects Co PSC ranks #124 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gulf Medical Projects Co PSC has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gulf Medical Projects Co PSC's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gulf Medical Projects Co PSC ranks #124 out of 664 companies for EBITDA Margin %. This places Gulf Medical Projects Co PSC in the top 19% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Gulf Medical Projects Co PSC's value of 23.09% is 125.6% above this benchmark. Historically, Gulf Medical Projects Co PSC's own EBITDA Margin % has ranged from 18.06 to 28.44 over the past decade. While the company's 10-year median is 21.46 vs. the industry median of 10.24, Gulf Medical Projects Co PSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gulf Medical Projects Co PSC's current EBITDA Margin % of 23.09% is 125.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gulf Medical Projects Co PSC and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gulf Medical Projects Co PSC's current EBITDA Margin % is 23.09%, which is near median its own 10-year median of 21.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Medical Projects Co PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Medical Projects Co PSC (ADX:GMPC) is currently considered Modestly Undervalued. The stock's GF Value™ is د.إ2.78, compared to a current price of د.إ2.31 — trading 16.9% below its estimated fair value. The current EBITDA Margin % is 23.09%, which is near median its 10-year median of 21.46 and 125.6% above the Healthcare Providers & Services industry median of 10.24. Gulf Medical Projects Co PSC's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gulf Medical Projects Co PSC (ADX:GMPC), the current EBITDA Margin % is 23.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gulf Medical Projects Co PSC (ADX:GMPC) Overvalued in 2026?
Based on GuruFocus' analysis, Gulf Medical Projects Co PSC stock appears to be undervalued.
The current stock price of د.إ2.31 is trading 16.9% below its estimated GF Value™ of د.إ2.78.
GuruFocus considers Gulf Medical Projects Co PSC to be Modestly Undervalued.
Key valuation signals for ADX:GMPC:
EBITDA Margin %: 23.09% (near median its 10-year median of 21.46)
GF Value™: د.إ2.78 vs. price of د.إ2.31 (16.9% below fair value)
Industry Position: 125.6% above the Healthcare Providers & Services median (#124 of 664)
No single metric tells the full story. See the ADX:GMPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gulf Medical Projects Co PSC provides medical and healthcare facilities. The company's main activities include general hospital, hospitals management, construction of medicine product factories and trading in medical equipment. Company has two reportable segments namely, Health services and others principally providing health, medical care and other related services and the Investments segment concerned with investment properties and investment in securities. Geographically, the company operates in the UAE market.
69GF Score
Get the complete analysis for ADX:GMPC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:GMPC has been successfully added to your 
